Business
Block Listing 6 Monthly Return
Block Listing 6 Monthly Return.
About this update from Shield Therapeutics Plc
[{"type":"text","content":"\n \n \n \n \n \n Shield Therapeutics plc\n \n \n (\"Shield\" or the \"Company\" or the \"Group\")\n \n \n \n \n \n Block Listing 6 Monthly Return\n \n \n \n \n \n \n \n \n \n Name of applicant:\n \n \n \n \n SHIELD THERAPEUTICS PLC\n \n \n \n \n \n \n \n \n \n Name of scheme:\n \n \n \n \n Shield Therapeutics Retention Share Plan\n \n \n \n \n \n \n Period of return:\n \n \n \n \n From:\n \n \n \n \n 30 September 2022\n \n \n \n \n To:\n \n \n \n \n 31 March 2023\n \n \n \n \n \n \n Balance of unallotted securities under scheme(s) from previous return:\n \n \n \n \n 39,794\n \n \n \n \n \n \n Plus:\n \n \n \n The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):\n \n \n \n \n NIL\n \n \n \n \n \n \n Less:\n \n \n \n Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):\n \n \n \n \n NIL\n \n \n \n \n \n \n Equals:\n \n \n \n Balance under scheme(s) not yet issued/allotted at end of period:\n \n \n \n \n 39,794\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Name of applicant:\n \n \n \n \n SHIELD THERAPEUTICS PLC\n \n \n \n \n \n \n \n \n \n Name of scheme:\n \n \n \n \n Shield Therapeutics plc 2016 Company Share Option Plan\n \n \n \n \n \n \n Period of return:\n \n \n \n \n From:\n \n \n \n \n 30 September 2022\n \n \n \n \n To:\n \n \n \n \n 31 March 2023\n \n \n \n \n \n \n Balance of unallotted securities under scheme(s) from previous return:\n \n \n \n \n 341,020\n \n \n \n \n \n \n Plus:\n \n \n \n The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):\n \n \n \n \n NIL\n \n \n \n \n \n \n Less:\n \n \n \n Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):\n \n \n \n \n NIL\n \n \n \n \n \n \n Equals:\n \n \n \n Balance under scheme(s) not yet issued/allotted at end of period:\n \n \n \n \n 341,020\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Name of applicant:\n \n \n \n \n SHIELD THERAPEUTICS PLC\n \n \n \n \n \n \n \n \n \n Name of scheme:\n \n \n \n \n The Shield Therapeutics plc 2016 Long Term Incentive Plan\n \n \n \n \n \n \n ...